{'fraction_non_alphanumeric': 0.01998262380538662, 'fraction_numerical': 0.0, 'mean_word_length': 5.329670329670329, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Impact of Real-Time Continuous Glucose Monitoring on Children and Their Families

Real-time continuous glucose monitoring (CGM) devices have great potential to improve glycemic management in children and adolescents with diabetes and other disorders of glucose regulation. These devices can be used as either adjuncts or replacements for traditional meters because they have additional features such as blood sugar alarms and glucose-trend information. These features allow for dynamic adjustments in therapy and, hopefully, will be key components to closed-loop insulin infusion devices. 
 
The DirectNet research group, which was created to study the use of new diabetes management technologies in pediatric and adolescent patient populations, is currently looking for the best methods to translate continuous glucose data into meaningful adjustments in therapy. This presentation examines possible ways to use CGM devices to their maximize benefits. Of note, not all of the devices discussed are Food and Drug Administration (FDA) approved (i.e. some are investigational) and those sensors that are FDA approved are not labeled for use in children.